25
Mar
2019
Tag: patient-centered marketing
27
Aug
2018
Bionest
Steps Toward the Use of Real World Evidence
“Real-world evidence” (RWE) is data on the use and accrued long-term benefits/risks of a drug or device that is gathered outside of a clinical trial — generally after the product has been approved. Clinical trials don’t often reflect the breadth and diversity of patient experience with a particular treatment that can be seen once the...
19
Feb
2018
Bionest
Reinventing Medical Affairs to the Benefit of All
The concept of patient-centric drug development has been a frequent topic of discussion in recent years. Increasingly, companies have moved to adopt practices that create more active, networked relationships and interactions between physicians, patients, advocates and drug developers. The aim of such practices is to better respond to patient and physician needs and concerns, while...
26
May
2017
Bionest
It’s ASCO Time Once Again!
ASCO is the largest annual gathering of the worldwide oncology community, and this year’s event takes place this coming weekend, from June 2-6 in Chicago, Illinois. About 10 days ago, the association released its program and a wide slate of abstracts that have given way to plenty of media reports and speculation about what other...
14
Nov
2016
Bionest
From Disease Treatment to Patient Care: Thoughts from ESMO 2016
The theme of patient centricity and care that we discussed at this year’s ASCO continued this autumn at ESMO 2016. The tagline of the conference was ‘From disease treatment to patient care,’ which according to the organizers, “intended to capture and integrate clinical research with patient needs, and reinforces our commitment to bring the best...
6
Jul
2016
Bionest
Collective Wisdom Around Oncology – Comments on ASCO 2016
The Bionest Oncology team spent a jam packed and exciting five days at ASCO 2016 earlier this month in Chicago. More than 30,000 oncology professionals gathered from all around the world to discuss the latest data and innovations in oncology, and it did not disappoint. The theme of ASCO this year was Collective Wisdom, which...
27
May
2016
Bionest
See you at ASCO 2016!
It’s nearly June, which means one thing for the Bionest Oncology team: ASCO is right around the corner. As we gear up for our time in Chicago, we are taking a look at some of the big topics and anticipated data we expect to see during the conference. The theme of ASCO this year is...
6
Apr
2016
Bionest
“Beyond the Pill” — Part Two: Value-Added Services Offer Benefit to Multiple Audiences
In our first “Beyond the Pill” post, we discussed the increasing move towards patient-centric programs that go past an actual prescription to help build relationships with patients and physicians and facilitate the provision of a number of related services to improve compliance and treatment outcomes and keep patients on drug long-term. The benefit of such...
31
Mar
2016
Bionest
“Beyond the Pill,” Part One: Value-Added Services Increasingly Needed Due to Changing Nature of Therapies
The notion of patient-centricity has gained increasing attention from drug developers and others in recent years, mostly in the area of chronic diseases and those requiring complex therapies. But value-added services, which go beyond simple initiatives addressed to patient compliance and access to therapy, are also gaining increasing attention from a variety of other audiences,...
8
Mar
2016